Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
2002 1
2010 1
2012 1
2013 1
2015 1
2019 1
2020 1
2023 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial.
Ryan P, Blanco JL, Masia M, Garcia-Fraile L, Crusells MJ, Domingo P, Curran A, Guerri-Fernandez R, Bernal E, Bravo J, Revollo B, Macias J, Tiraboschi JM, Montejano R, Amador C, Torralba M, Merino D, Diaz-Brito V, Galindo MJ, Ferra S, Villoslada A, Losa JE, Fanjul FJ, Perez-Stachowski X, Peraire J, Portilla J, de la Fuente S, Dueñas C, Vazquez MJ, Di Gregorio S, Esteban H, Gil P, de Miguel M, Alejos B, Martínez E; PASO-DOBLE study group. Ryan P, et al. Among authors: crusells mj. Lancet HIV. 2025 Jul;12(7):e473-e484. doi: 10.1016/S2352-3018(25)00105-5. Epub 2025 Jun 7. Lancet HIV. 2025. PMID: 40489982 Clinical Trial.
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).
Buzón-Martín L, Montes ML, Pedrero R, Galindo MJ, Santacreu-Guerrero M, Alemán MR, Torralba M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello A, Crusells MJ, Navarro MDC, Aguilera M, Hidalgo-Tenorio C, Morano-Amado LE, Vinuesa D, De Andres C, Bernal-Morell E, Martínez-Álvarez RM, Cabello-Clotet N, Tiraboschi J, Montero MDC, Vivancos-Gallego MJ, Díez C, Calderón R, De Zárraga MA, Gisbert L, Romero-Palacios A, Cabo R, Soler JF, Sepúlveda MA, Sánchez-Guirao AJ, Escrich C, Arnaiz De Las Revillas F, Ferreira E, Valentín B, Lérida A, Llenas-García J, Gómez A, Losa JE, Alonso B, Sanz J, Masiá M, Pernas H, Corte JJ, Garcinuño MÁ, Gainzarain JC, Estébanez M, García-Navarro MDM, Barragán P, Ramos N, Clavero M, Millán M, Del Álamo M, Egido M, De La Calle B, Ferrero OL, Troya J. Buzón-Martín L, et al. Among authors: crusells mj. J Antimicrob Chemother. 2025 Dec 2;80(12):3438-3451. doi: 10.1093/jac/dkaf389. J Antimicrob Chemother. 2025. PMID: 41128149
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study).
Serrano-Villar S, Martín-Pedraza L, Tiraboschi J, Novella M, Cabello-Úbeda A, López-Cortés L, Busca C, Torralba M, Crusells MJ, Hidalgo-Tenorio C, Estrada V, Del Amo-de Palacios A, Díaz de Santiago A, Fons-Contreras M, Santos J, Bernal E, Montero-Alonso M, Troya J, Blanco JR, Burgos J, de Miguel M, Moreno S. Serrano-Villar S, et al. Among authors: crusells mj. Clin Infect Dis. 2025 Oct 10:ciaf565. doi: 10.1093/cid/ciaf565. Online ahead of print. Clin Infect Dis. 2025. PMID: 41070447
[Osseous hydatidosis: Apropos of two cases].
Roche F, Crusells MJ, Cuesta J, Letona S, Sanjoaquín I, De Miguel R, Amiguet JA. Roche F, et al. Among authors: crusells mj. Enferm Infecc Microbiol Clin. 2002 Mar;20(3):134-5. doi: 10.1016/s0213-005x(02)72768-7. Enferm Infecc Microbiol Clin. 2002. PMID: 11904091 Spanish. No abstract available.
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study).
Pasquau J, de Jesus SE, Arazo P, Crusells MJ, Ríos MJ, Lozano F, de la Torre J, Galindo MJ, Carmena J, Santos J, Tornero C, Verdejo G, Samperiz G, Palacios Z, Hidalgo-Tenorio C; RIDAR Study Group. Pasquau J, et al. Among authors: crusells mj. BMC Infect Dis. 2019 Feb 28;19(1):207. doi: 10.1186/s12879-019-3817-6. BMC Infect Dis. 2019. PMID: 30819101 Free PMC article.
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997-2017).
Beltrán-Pavez C, Gutiérrez-López M, Rubio-Garrido M, Valadés-Alcaraz A, Prieto L, Ramos JT, Jiménez De Ory S, Navarro M, Díez-Romero C, Pulido F, Valencia E, Holguín Á; Madrid Cohort of HIV-Infected Children integrated in the Pediatric Branch of the Spanish National AIDS Network (CoRISpe). Beltrán-Pavez C, et al. Sci Rep. 2020 Oct 9;10(1):16891. doi: 10.1038/s41598-020-70861-x. Sci Rep. 2020. PMID: 33037235 Free PMC article.
12 results